Skip to main content
. 2017 Jul 31;2017(7):CD009377. doi: 10.1002/14651858.CD009377.pub3

Comparison 16. HALOPERIDOL vs COMBINATIONS: a. HALOPERIDOL + LEVOMEPROMAZINE.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Global outcome: 1. No overall improvement 1 19 Risk Ratio (M‐H, Fixed, 95% CI) 8.18 [0.50, 133.66]